Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1

被引:2
|
作者
Li, Mao [1 ]
Wang, Zhanjun [2 ]
Cui, Fang [1 ]
Yang, Fei [1 ]
Wang, Hongfen [1 ]
Huang, Xusheng [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurol, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
基金
中国国家自然科学基金;
关键词
myotonic dystrophy type 1; MIRS; multisystemic impairment; cataract; hypogonadism; cardiac abnormalities; QUALITY-OF-LIFE; CTG REPEAT; INVOLVEMENT; PREVALENCE; DISABILITY; FEATURES; COHORT; DEATH; AGE;
D O I
10.3389/fneur.2020.00277
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disease characterized by muscle weakness and multisystemic impairments, which significantly impact the quality of life. There is currently an increasing consensus on the necessity of a multidisciplinary assessment in patients with DM1, to improve the management of the disease. Methods: To analyze the prevalence and pairwise relationships between various organs involved, we performed a retrospective study by reviewing demographic and clinical information of DM1 patients including age, disease duration, clinical history, muscular impairment rating scale score (MIRS), results of blood biochemistry, electrocardiogram, echocardiography, and ophthalmologic examination. Results: Ninety three DM1 patients (60 males and 33 females), aged 34.7 +/- 12.6 (mean +/- standard deviation) years were recruited. Of which, two congenital cases were of maternal and paternal inheritance, respectively. In the other 91 patients, cataract was found in 44.1% of patients, followed by hypogonadism (40.8%), frontal balding (40.7%), and cardiac abnormalities (34.5%). Thyroid dysfunction and insulin insensitivity were relatively uncommon. Age (p < 0.001) is independently correlated with cataract, and MIRS correlates positively with cardiac abnormalities (p = 0.005) and frontal balding (p = 0.015). Male patients more frequently had frontal balding (Risk ratio, 3.98; 95% confidence interval, 1.493-10.611) compared with female patients. Male patients with cataract presented more frequent cardiac abnormalities (Risk ratio, 4.40; 95% confidence interval, 1.055-18.358) compared with non-cataract male patients. Hypogonadism in male patients was characterized as decreased testosterone level, accompanied by elevated levels of luteinizing hormone and follicle-stimulating hormone. Conclusions: In Chinese patients with DM1, we conclude that (1) cataract, hypogonadism, frontal balding and cardiac abnormalities are frequently observed; (2) age is an independent indicator to cataract and MIRS is the only predictor for cardiac abnormalities and frontal balding; (3) a positive correlation between ophthalmologic and cardiac impairments in male patients is found; (4) endocrine abnormalities show diverse manifestations and hormone tests are recommended; (5) particular attention should be given to patients with older age and higher MIRS score.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Cognitive impairment and quality of life in patients with myotonic dystrophy type 1
    Fujino, Haruo
    Shingaki, Honoka
    Suwazono, Shugo
    Ueda, Yukihiko
    Wada, Chizu
    Nakayama, Takahiro
    Takahashi, Masanori P.
    Imura, Osamu
    Matsumura, Tsuyoshi
    MUSCLE & NERVE, 2018, 57 (05) : 742 - 748
  • [32] Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1
    Mahdavi, Manijeh
    Prevost, Karine
    Balthazar, Philippe
    Hus, Isabelle Fisette-Paul
    Duchesne, Elise
    Dumont, Nicolas
    Gagne-Ouellet, Valerie
    Gagnon, Cynthia
    Laforest-Lapointe, Isabelle
    Masse, Eric
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2024, 23 : 2097 - 2108
  • [33] Analysis of Corneal Phenotypes in Japanese Patients With Myotonic Dystrophy Type 1
    Kubo, Kenya
    Oie, Yoshinori
    Koto, Ryota
    Nishida, Nozomi
    Kai, Chifune
    Maeno, Sayo
    Kubota, Tomoya
    Nakamori, Masayuki
    Takahashi, Masanori P.
    Tsujikawa, Motokazu
    Nishida, Kohji
    CORNEA, 2025, 44 (04) : 412 - 417
  • [34] Myotonic dystrophy type 1: clinical manifestations in children and adolescents
    Ho, Genevieve
    Carey, Kate A.
    Cardamone, Michael
    Farrar, Michelle A.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (01) : 48 - 52
  • [35] Respiratory dysfunction in myotonic dystrophy type 1: A systematic review
    Hawkins, A. M.
    Hawkins, C. L.
    Razak, K. Abdul
    Khoo, T. K.
    Tran, K.
    Jackson, R. V.
    NEUROMUSCULAR DISORDERS, 2019, 29 (03) : 198 - 212
  • [36] Peripheral neuropathy in myotonic dystrophy type 1
    Hermans, Mieke C. E.
    Faber, Catharina G.
    Vanhoutte, Els K.
    Bakkers, Mayienne
    De Baets, Marc H.
    de Die-Smulders, Christine E. M.
    Merkies, Ingemar S. J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 (01) : 24 - 29
  • [37] Visual Function in Congenital and Childhood Myotonic Dystrophy Type 1
    Ekstrom, Anne-Berit
    Tulinius, Mar
    Sjostrom, Anders
    Aring, Eva
    OPHTHALMOLOGY, 2010, 117 (05) : 976 - 982
  • [38] Myotonic dystrophy type 1 presenting with dyspnea: A case report
    Jia, Yu-Xi
    Dong, Chun-Ling
    Xue, Jia-Wei
    Duan, Xiao-Qin
    Xu, Ming-Yu
    Su, Xiao-Min
    Li, Ping
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (20) : 7060 - 7067
  • [39] Disease burden of myotonic dystrophy type 1
    Erik Landfeldt
    Nikoletta Nikolenko
    Cecilia Jimenez-Moreno
    Sarah Cumming
    Darren G. Monckton
    Grainne Gorman
    Chris Turner
    Hanns Lochmüller
    Journal of Neurology, 2019, 266 : 998 - 1006
  • [40] Targeting Myotonic Dystrophy Type 1 with Metformin
    Garcia-Puga, Mikel
    Saenz-Antonanzas, Ander
    Matheu, Ander
    Lopez de Munain, Adolfo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)